Research Paper Volume 14, Issue 11 pp 4827—4838

Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study

class="figure-viewer-img"

Figure 2. Numbers of SCLC patients who received chemotherapy over time (2004–2015). There were 12,499, 12,264 and 12,373 SCLC patients aged ≤ 80 years who received chemotherapy in 2004–2007, 2008–2011 and 2012–2015, accounting for 72%, 73% and 74% of all young patients respectively. During the same periods, 907 (44%), 991 (43%) and 876 (41%) patients older than 80 years underwent chemotherapy respectively. The proportion of patients receiving chemotherapy did not change significantly over time. Abbreviations: SCLC: Small cell lung cancer.